Gilles Bertschy

6.3k total citations · 2 hit papers
167 papers, 4.7k citations indexed

About

Gilles Bertschy is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, Gilles Bertschy has authored 167 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Psychiatry and Mental health, 40 papers in Pharmacology and 37 papers in Experimental and Cognitive Psychology. Recurrent topics in Gilles Bertschy's work include Bipolar Disorder and Treatment (44 papers), Treatment of Major Depression (38 papers) and Schizophrenia research and treatment (27 papers). Gilles Bertschy is often cited by papers focused on Bipolar Disorder and Treatment (44 papers), Treatment of Major Depression (38 papers) and Schizophrenia research and treatment (27 papers). Gilles Bertschy collaborates with scholars based in France, Switzerland and Italy. Gilles Bertschy's co-authors include Guido Bondolfi, Jean‐Michel Aubry, Michèle Schwald, Félicien Karege, Guillaume Perret, Nicola Gervasoni, Marianne Gex‐Fabry, Pierre Baumann, Chin B. Eap and Enzo Pasquale Scilingo and has published in prestigious journals such as PLoS ONE, NeuroImage and Scientific Reports.

In The Last Decade

Gilles Bertschy

161 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Decreased serum brain-derived neurotrophic factor levels in major depressed patients

2002 992 citations Félicien Karege, Guillaume Perret et al. profile →
Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity

2005 500 citations Félicien Karege, Guido Bondolfi et al. Biological Psychiatry profile →

Peers

Countries citing papers authored by Gilles Bertschy

Since Specialization

Citations

This map shows the geographic impact of Gilles Bertschy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Bertschy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Bertschy more than expected).

Fields of papers citing papers by Gilles Bertschy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilles Bertschy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Bertschy. The network helps show where Gilles Bertschy may publish in the future.

Co-authorship network of co-authors of Gilles Bertschy

This figure shows the co-authorship network connecting the top 25 collaborators of Gilles Bertschy. A scholar is included among the top collaborators of Gilles Bertschy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles Bertschy. Gilles Bertschy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults 2024 ·Pharmacoepidemiology and Drug Safety ·Estelle Ayme‐Dietrich, Florentia Kaguelidou, Gilles Bertschy, Laurent Chouchana	0
2	Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT 2023 ·Frontiers in Psychiatry ·(unknown), (unknown), (unknown), Sébastien Weibel, (unknown), (unknown), (unknown), Fabrice Berna, (unknown), Frédéric Blanc, (unknown), (unknown), (unknown), (unknown), (unknown), Hervé Javelot, (unknown), Gilles Bertschy, Jack Foucher	2
3	Impact of the first wave of the COVID-19 pandemic on French Health students 2022 ·L Encéphale ·(unknown), Ariel Frajerman, Bruno Falissard, Gilles Bertschy, B. Diquet, (unknown)	14
4	Dynamic Functional Connectivity in Adolescence-Onset Major Depression: Relationships With Severity and Symptom Dimensions 2021 ·Biological Psychiatry Cognitive Neuroscience and Neuroimaging ·(unknown), Marie‐Laure Paillère Martinot, (unknown), (unknown), A. Kipman, Christian Trichard, (unknown), Coline Stordeur, A. Galinowski, Irina Filippi, Gilles Bertschy, Sébastien Weibel, (unknown), Frédéric Limosin, David Cohen, Jean‐Luc Martinot, Éric Artiges	20
5	Plasma Concentrations and Cardiovascular Effects of Citalopram Enantiomers After Oral Versus Infusion Citalopram Therapy in Dextromethorphan-Mephenytoin-Phenotyped Patients With Major Depression 2020 ·Therapeutic Drug Monitoring ·Pierre Baumann, Gilles Bertschy, (unknown), R. Nil	1
6	Novel method to measure temporal windows based on eye movements during viewing of the Necker cube 2020 ·PLoS ONE ·(unknown), (unknown), Luisa Weiner, Gilles Bertschy, Anne Giersch	7
7	Major depression: does gender influence the risk of recurrence? A systematic review 2016 ·The European Journal of Psychiatry ·Gilles Bertschy, Michel Velten, Sébastien Weibel	7
8	Neural substrates of cognitive switching and inhibition in a face processing task 2013 ·NeuroImage ·Camille Piguet, Virginie Sterpenich, Martin Desseilles, Yann Cojan, Gilles Bertschy, Patrik Vuilleumier	23
9	Is there a place for tricyclic antidepressants and subsequent augmentation strategies in obtaining remission for patients with treatment resistant depression? 2008 ·Pharmacological Research ·Nicola Gervasoni, Jean‐Michel Aubry, Marianne Gex‐Fabry, Gilles Bertschy, Guido Bondolfi	10
10	The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients 2006 ·Journal of Psychiatric Research ·Jean‐Michel Aubry, Nicola Gervasoni, Christian Osiek, Guillaume Perret, Michel F. Rossier, Gilles Bertschy, Guido Bondolfi	53
11	Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity breakdown → 2005 ·Biological Psychiatry ·Félicien Karege, Guido Bondolfi, Nicola Gervasoni, Michèle Schwald, Jean‐Michel Aubry, Gilles Bertschy	500
12	Possible Induction of Mania or Hypomania by Atypical Antipsychotics 2004 ·The Journal of Clinical Psychiatry ·Fady Rachid, Gilles Bertschy, Guido Bondolfi, Jean‐Michel Aubry	45
13	Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode 2004 ·Journal of Psychiatric Research ·Nicola Gervasoni, Gilles Bertschy, Christian Osiek, Guillaume Perret, (unknown), Jean Golaz, Michel F. Rossier, Guido Bondolfi, Jean‐Michel Aubry	35
14	Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results 2003 ·Drug and Alcohol Dependence ·(unknown), Bernard Favrat, Martine Monnat, Jean‐Bernard Daeppen, C Schnyder, Gilles Bertschy, Jacques Besson	15
15	Long-term treatment of depression 1997 ·International Clinical Psychopharmacology ·R. Baumann, Gilles Bertschy	41
16	Clomipramine plasma levels among depressed outpatients in Benin, west Africa: drug compliance and comparison with Caucasian patients. 1992 ·PubMed ·Gilles Bertschy, S Vandel	2
17	METABOLIC INTERACTION BETWEEN TRICYCLIC ANTIDEPRESSANT AND FLUVOXAMINE AND FLUOXETINE, A PHARMACOGENETIC APPROACH 1992 ·Clinical Neuropharmacology ·Gilles Bertschy, S Vandel, (unknown), B Bonin, S. Bouquet, Pierre Baumann, R Volmat, D. Sechter, P Bízouard	3
18	PHARMACOKINETICS OF FLUOXETINE AND FLUVOXAMINE IN DEPRESSED PATIENTS: PERSONAL RESULTS 1992 ·Clinical Neuropharmacology ·S. Bouquet, S Vandel, Gilles Bertschy, B Bonin, B Vandel, D. Sechter, P Bízouard	5
19	Obsessive-Compulsive Disorders in Benin: Five Case Reports 1991 ·Psychopathology ·Gilles Bertschy, (unknown)	14
20	Amitriptyline: linear or nonlinear kinetics in every day practice? 1989 ·European Journal of Clinical Pharmacology ·S Vandel, Gilles Bertschy, B Vandel, G Allers, R Volmat	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact